Enzymatica AB

Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products

Cold and flu,enzyme (trypsin),and barrier technology

Enzymatica ab operates in the Medical equipment manufacturing industry.

Enzymatica ab's revenue is 1m - 10m

Enzymatica ab has 11 - 50 employees.